Malignant biliary obstruction
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients with unresectable distal malignant biliary obstruction, not limited to primary disease. 2) Patients with predictable prognosis of more than 4 months. 3) Patients with written informed consent. 4) Patients with performance status 0-3.
Exclusion criteria
Exclusion criteria: 1) Patients with massive ascites. 2) Patients with severely impaired organ function. 3) Patients for whom endoscopic biliary drainage is difficult. 4) Patients with duodenal obstruction. 5) Patients whose antithrombotic drugs cannot be stopped. 6) Patients considered ineligible for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to stent dysfunction | — |
Secondary
| Measure | Time frame |
|---|---|
| Effectiveness 1) Stent patency period 2) Survival period 3) Event free survival 4) Stent patency period after reintervention 5) Time to stent dysfunction after reintervention 6) Cost effectiveness Safety 1) Early complications 2) Late complications 3) Technical success rate 4) Removability of the stent 5) Removability of the second stent | — |
Countries
Japan
Contacts
Faculty of Medicine, Kyoto University Department of Gastroenterology and Hepatology